ClinicalTrials.gg
Not yet recruitingNCT05869578RAMPUpdated May 22, 2023

Registry of Anesthesia and Perioperative Medicine

An observational study in Perioperative Complication, Perioperative/Postoperative Complications and Anesthesia Morbidity, sponsored by Clinica Alemana de Santiago. Not yet recruiting at 1 site in Chile. Per ClinicalTrials.gov, last updated 2023-05-22.

Sponsored by Clinica Alemana de Santiago · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
10,000
Sex
All
01

Study summary

To assess mortality and morbidity associated to anesthesia interventions

Read the detailed description

Currently evidence-based medicine is one of the most important tools guiding our medical practice. Part of this evidence has been generated from clinical records, which has allowed access to large databases from which relevant information has been obtained for perioperative risk stratification, searching for complications, having specific information on procedures, among others.

A clear example, especially useful daily in anesthesia work, is the NSQIP score, a tool that allows calculating perioperative risk according to the conditions of the patient and the surgery. NSQIP score is considered to make decisions in both the American and the European guidelines for preoperative evaluation for surgery.

Latin-American or Chilean databases are not available at the present time. Chile lacks of population perioperative databases, methodology and practice of medicine outcomes records, thus making necessary the generation of a retrospective/prospective registry.

The investigators expect that this registry will allow the collection of perioperative information appropriate to characterize the Chilean population, observe its evolution, and detect risk factors. Moreover, this registry will grant the investigators the means to design new research studies that may allow them to gather medical evidence of superior quality, thus benefiting patients with the best and safest interventions and procedures.

02

Conditions studied

  • Perioperative Complication
  • Perioperative/Postoperative Complications
  • Anesthesia Morbidity
  • Anesthesia; Adverse Effect
  • Anesthesia Complication
  • Anesthesia; Reaction
03

In context

Postoperative Complications

1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.

This study's planned enrollment of 10,000 is above the median of 251 across 541 observational studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

Clinica Alemana de Santiago is the lead sponsor of 11 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Individuals of all ages being admitted at Clinica Alemana de Santiago that will require or were in care by an anesthesiologist.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All individuals
  • Individuals agreeing to participate in the study by signing a consent

Exclusion criteria

Exclusion Criteria:

  • The subjects who had insufficient data in their files
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
10,000 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Interventions

  • ProcedureAnesthesia Intervention

    Patients exposed to any anesthesia intervention will be assessed to whether the exposure to anesthesia confers a risk for perioperative outcomes

06

What researchers measure

Primary outcomes

  1. All-cause mortality rate in the postoperative period

    Posoperative mortality of individuals exposed to any anesthesia related intervention or event

    Time frame: 30 days

  2. All-cause mortality rate in the posoperative period

    Posoperative mortality of individuals exposed to any anesthesia related intervention or event

    Time frame: one year

  3. Number of patients presenting a complication in the posoperative period

    Perioperative morbidity of individuals exposed to any anesthesia related intervention or event.

    Time frame: 30 days

  4. Number of patients who needed rehospitalization in the posoperative period

    Posoperative rehospitalization rate of individuals exposed to any anesthesia related intervention or event, after primary discharge

    Time frame: 7 days after primary discharge

  5. Number of deaths in the postoperative period after readmission

    In-hospital mortality of patients that were readmitted after primary discharge

    Time frame: up to 30 days

Secondary outcomes

  1. Change from baseline in pain, as measured by the visual analog scale (VAS)

    Scores are measured on a 10-point VAS. The VAS ranges from 0 to 10 with 0 indicating no pain, and higher scores indicating greater pain.

    Time frame: Baseline pre-intervention VAS, postoperative/intervention 1 hour VAS, postoperative/intervention 24 hour VAS

  2. Number of patients that develops postoperative acute kidney injury, as measured by Kidney Disease Improving Global Outcomes (KIDGO)-2012 serum creatinine criteria

    Criteria for developing acute kidney injury are: Increase in serum creatinin by ≽0.3 mg/dl (≽26.5lmol/l) within 48hours; or Increase in serum creatinine ≽1.5 times baseline, which is known or presumed to have occurred within the prior 7 days; or Urine volume \< 0.5ml/kg/h for 6hours.

    Time frame: 7 and 30 days

  3. Number of patients that develops postoperative Major Acute Cardiac Events (MACE), as defined by the American Heart Association

    Criteria for MACE are the development of any of the following conditions Non-fatal stroke Non-fatal myocardial infarction Cardiovascular death

    Time frame: 7 and 30 days

  4. Number of patients that develop posoperative chronic pain as measured by visual analog scale

    Scores are measured on a 10-point VAS. The VAS ranges from 0 to 10 with 0 indicating no pain, and higher scores indicating greater pain.

    Time frame: 3, 6, and 12 months

07

Study locations

1 site
  • Clinica Alemana de Santiago
    Santiago, Region Metropolitana De Santiago 7591538, Chile
    • Patricio A Leyton, MD · Contactpleytonb@alemana.cl · +562222101111
    • Javiera A Vargas, MD · Principal investigator
    • Patricio A Leyton, MD · Sub investigator
08

References and documents

Publications

  • Abdel-Kader AK, Eisenkraft JB, Katz DJ. Overview and Limitations of Database Research in Anesthesiology: A Narrative Review. Anesth Analg. 2021 Apr 1;132(4):1012-1022. doi: 10.1213/ANE.0000000000005346. PubMed 33346984 ↗
  • Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, De Hert S, Ford I, Gonzalez Juanatey JR, Gorenek B, Heyndrickx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Luescher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Uva MS, Voudris V, Funck-Brentano C; Authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol. 2014 Oct;31(10):517-73. doi: 10.1097/EJA.0000000000000150. No abstract available. PubMed 25127426 ↗
  • Gupta PK, Gupta H, Sundaram A, Kaushik M, Fang X, Miller WJ, Esterbrooks DJ, Hunter CB, Pipinos II, Johanning JM, Lynch TG, Forse RA, Mohiuddin SM, Mooss AN. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation. 2011 Jul 26;124(4):381-7. doi: 10.1161/CIRCULATIONAHA.110.015701. Epub 2011 Jul 5. PubMed 21730309 ↗
  • Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 9;130(24):2215-45. doi: 10.1161/CIR.0000000000000105. Epub 2014 Aug 1. No abstract available. PubMed 25085962 ↗
  • Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021 Nov 6;21(1):241. doi: 10.1186/s12874-021-01440-5. PubMed 34742250 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2023; primary completion for Jan 2035, 139 months later.

Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 139 months is above that.

Counting every sponsor, half of 281 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 27, 2023
First posted
May 22, 2023
StartEst.
Jun 1, 2023
Primary completionEst.
Jan 1, 2035
CompletionEst.
Jan 1, 2045
Last update
May 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05869578
Lead sponsor
Clinica Alemana de Santiago
Responsible party
Sponsor
First posted
May 22, 2023
Start date
Jun 1, 2023 (estimated)
Primary completion
Jan 1, 2035 (estimated)
Completion
Jan 1, 2045 (estimated)
Last update
May 22, 2023

Study contacts

Javiera A Vargas, MD
Contact
jvargasz@alemana.cl
+56222101111 ext. 1699
Patricio A Leyton, MD
Contact
pleytonb@alemana.cl
+5622101111 ext. 1699

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion